Bioventus Inc. BVS
Set alert
13.15 USD -0.17 -1.31%
At close · Nov 2
10.96 -2.19 -16.65%
After hours · Nov 2, 6:57 PM ET
13.07 Day range 13.73
6.47 52-week range 15.89
- YTD
- +76.75%
- 1 year
- +100.76%
- Open
- 13.52
- Prev close
- 13.33
- Mkt cap
- 898.21M
- Vol
- 681.38K
- Avg vol
- 562.45K
- EPS
- 0.77
- P/E
- 17.08
- Div yield
- 0.00%
More statistics
- Low
- 13.07
- High
- 13.73
- Forward P/E
- 16.16
- Beta
- 0.64
- Short ratio
- 7.53
- Inst. own
- 84.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 13.72
- 200-d avg
- 10.84
- 1y target
- 17.60
1D chart
Events in this range
- Nov 2, 2026Earnings: —; estimate 0.1496; surprise —%
Signals (74)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | 3:45 PM | 8 hours ago |
| SMA: Bullish | 3:43 PM | 8 hours ago |
| SMA: Bullish | 3:43 PM | 8 hours ago |
| MACD: Buy Signal | 3:36 PM | 8 hours ago |
| MACD: Sell Signal | 3:29 PM | 8 hours ago |
| MACD: Buy Signal | 3:21 PM | 9 hours ago |
| MACD: Sell Signal | 3:15 PM | 9 hours ago |
| MACD: Buy Signal | 3:04 PM | 9 hours ago |
| MACD: Sell Signal | 3:02 PM | 9 hours ago |
| RSI: Oversold | 3:01 PM | 9 hours ago |
| SMA: Bearish | 3:00 PM | 9 hours ago |
| MACD: Buy Signal | 2:48 PM | 9 hours ago |
| MACD: Sell Signal | 2:34 PM | 9 hours ago |
| RSI: Oversold | 2:34 PM | 9 hours ago |
| MACD: Buy Signal | 2:30 PM | 9 hours ago |
| MACD: Sell Signal | 2:18 PM | 10 hours ago |
| RSI: Oversold | 2:18 PM | 10 hours ago |
| SMA: Bearish | 2:17 PM | 10 hours ago |
| SMA: Bearish | 2:17 PM | 10 hours ago |
| MACD: Buy Signal | 2:15 PM | 10 hours ago |
Newest 20 of 74.
Financial health
Altman Z-Score
2.14 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 3
- P/B 2
Valuation
P/E 21.9×
FY 2016 5y median -1.0× FY 2025
P/S 0.9×
FY 2016 5y median 0.9× FY 2025
P/B 2.7×
FY 2016 5y median 1.9× FY 2025
P/FCF 6.9×
FY 2016 5y median 18.2× FY 2025
EV/EBITDA 7.6×
FY 2016 5y median 7.6× FY 2025
EV/Sales 1.3×
FY 2016 5y median 1.3× FY 2025
FCF Yield 14.4%
FY 2016 5y median 2.4% FY 2025
Profitability
Gross Margin 67.3%
FY 2016 5y median 67.3% FY 2025
Operating Margin 10.3%
FY 2016 5y median -2.1% FY 2025
Net Margin 4.0%
FY 2016 5y median -5.9% FY 2025
ROE 12.3%
FY 2016 5y median -22.7% FY 2025
ROIC 10.8%
FY 2016 5y median -2.0% FY 2025
ROA 3.3%
FY 2016 5y median -4.6% FY 2025
Growth (YoY)
Revenue -0.9%
FY 2016 FY 2025
Operating Income 588.7%
FY 2016 FY 2025
EPS (diluted) 163.5%
FY 2016 FY 2025
Free Cash Flow 89.0%
FY 2016 FY 2025
Financial Health
Current Ratio 1.7×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.2×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 1.7×
FY 2016 5y median 1.7× FY 2025
Net Debt / EBITDA 2.6×
FY 2016 5y median 2.6× FY 2025
Interest Coverage 2.2×
FY 2016 5y median -0.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
